Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MakeMyTrip (MMYT) Other Non-Current Liabilities (2016 - 2025)

MakeMyTrip has reported Other Non-Current Liabilities over the past 16 years, most recently at $11.4 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 9.34% year-over-year to $11.4 million; the TTM value through Dec 2025 reached $11.4 million, down 9.34%, while the annual FY2025 figure was $12.4 million, 33.38% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $11.4 million at MakeMyTrip, down from $11.5 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $32.0 million in Q1 2021 and troughed at -$26.3 million in Q1 2022.
  • A 5-year average of $8.1 million and a median of $10.2 million in 2021 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 182.26% in 2022 and later soared 772.5% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $5.3 million in 2021, then dropped by 11.7% to $4.7 million in 2022, then grew by 2.06% to $4.7 million in 2023, then soared by 164.9% to $12.6 million in 2024, then fell by 9.34% to $11.4 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for MMYT at $11.4 million in Q4 2025, $11.5 million in Q3 2025, and $12.4 million in Q2 2025.